Hubei widely chemical technology Co., Ltd

Crizotinib

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  (5-(pyridin-3-yl)-1,3,4-oxadiazol-2-yl)methanamine;3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine;3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine;Crizotinib;PF2341066;2-pyridinamine, 3-[(1r)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1h-pyrazol-4-yl]-;PF-02341066;

• CAS NO :

  877399-52-5

• EC NO :

• Molecular Formula :

  C₂₁H₂₂Cl₂FN₅O

• Molecular Weight :

  450.3367

• Main Specifications :

  99%

• InChI :

  InChI=1/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1

• Packing :

  1gram bottle /bags 1kg /bag 25kg/drum.

• Product description :

  English name: Crizotinib

  Chemical name: 2-Pyridinamine,3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]

   

  Molecular formula: C21H22Cl2FN5O               Molecular weight: 450.34

  CAS RN: 877399-52-5

  Application: pharmaceutical raw material

   

  Specification

  Purity	99%
  Properties	white crystallized powder
  Quality standard	Enterprise standard
  Melting point	166-170°C
  Related substances	0.16%
  Loss on drying	0.06%
  Residue on ignition	0.02%
  Chloride	<0.014
  Heavy Metals	<20ppm
  Microbial Limit	<20ppm

   

  Application: pharmaceutical raw material

  Main application: Treat abnormal anaplastic lymphoma kinase (ALK) gene rearranged end-stage non-small cell lung cancer

   

  Packaging: 1gram bottle /bags 1kg /bag 25kg/drum.

   

  Hubei Widely Chemical Technology Co., Ltd. is a professional production and sales of  bulk drugs, intermediates GMP factory , welcome to inquire  pharmaceutical raw materials prices , quality standards and other informations, hope to establish long-term business relationship with you !

• Uses :

  Treat abnormal anaplastic lymphoma kinase (ALK) gene rearranged end-stage non-small cell lung cancer

• Molecular Structure :